A detailed history of Susquehanna International Group, LLP transactions in Kempharm, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 214,798 shares of KMPH stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
214,798
Previous 138,504 55.08%
Holding current value
$1.06 Million
Previous $684,000 55.12%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
76,294 Added 55.08%
214,798 $1.06 Million
Q2 2024

Aug 15, 2024

BUY
N/A
49,895 Added 56.31%
138,504 $684,000
Q1 2024

May 07, 2024

SELL
N/A
-26,253 Reduced 22.86%
88,609 $437,000
Q4 2023

Feb 14, 2024

BUY
N/A
70,457 Added 158.67%
114,862 $567,000
Q3 2023

Nov 14, 2023

BUY
N/A
2,619 Added 6.27%
44,405 $219,000
Q2 2023

Aug 11, 2023

SELL
$4.94 - $6.29 $787,366 - $1 Million
-159,386 Reduced 79.23%
41,786 $206,000
Q1 2023

May 16, 2023

BUY
$4.13 - $6.27 $128,682 - $195,360
31,158 Added 18.33%
201,172 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$4.12 - $5.62 $104,108 - $142,011
25,269 Added 17.46%
170,014 $780,000
Q3 2022

Nov 14, 2022

SELL
$4.5 - $6.85 $86,202 - $131,218
-19,156 Reduced 11.69%
144,745 $903,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $5.21 $100,745 - $130,567
-25,061 Reduced 13.26%
163,901 $731,000
Q1 2022

May 16, 2022

BUY
$5.0 - $9.26 $574,565 - $1.06 Million
114,913 Added 155.19%
188,962 $950,000
Q4 2021

Feb 14, 2022

SELL
$7.6 - $10.26 $3.25 Million - $4.39 Million
-427,882 Reduced 85.25%
74,049 $645,000
Q3 2021

Nov 15, 2021

BUY
$8.72 - $13.31 $1.25 Million - $1.9 Million
142,870 Added 39.79%
501,931 $4.68 Million
Q2 2021

Aug 11, 2021

BUY
$8.52 - $15.47 $1.38 Million - $2.51 Million
162,002 Added 82.21%
359,061 $4.6 Million
Q1 2021

May 17, 2021

BUY
$5.6 - $13.47 $1.1 Million - $2.65 Million
197,059 New
197,059 $1.81 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.